Le Lézard
Classified in: Health, Covid-19 virus
Subjects: MAV, CCA, PSF, NTA, CFG

Media Advisory - Technical Briefing on COVID-19 in Indigenous Communities


OTTAWA, April 2, 2020 /CNW/ - Please be advised that Valerie Gideon, Senior Assistant Deputy Minister for Indigenous Services Canada, and Dr. Tom Wong, Chief Medical Officer of Public Health, will lead a Technical Briefing on prevention and preparedness for     COVID-19 in Indigenous communities.    

Date:  April 2, 2020
Time: 3:00 PM (EST)

Where: Teleconference

Dial-in information for Technical Briefing:
Media can participate by phone by dialing:  
1-888-265-0903 / 613-960-7527
Conference ID #: 5979068#

Follow us on Twitter:
Minister Marc Miller
(https://twitter.com/Min_IndServ) 

GovCan ? Indigenous
(https://twitter.com/GCIndigenous)

SOURCE Indigenous Services Canada


These press releases may also interest you

at 07:59
Green Security Partners with Spire Capital and Strattam Capital
Green Security, a leading provider of SaaS healthcare compliance and access management solutions, announced a majority growth investment, led by Spire Capital and Strattam Capital. Founded by CEO Shawn Fitzgibbons, Green Security's software provides...

at 07:55
Syra Health Wins Award to Develop Health Equity Accelerator Plan for the City of Portland in Maine
Syra Health Corp. ("Syra Health" or the "Company"), a healthcare technology company with a mission to improve healthcare by providing innovative services and technology solutions, announced today that it has been selected by the City of Portland in...

at 07:50
Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 ? 8th, 2024
Algernon Pharmaceuticals Inc. (the "Company" or "AGN Pharma") , a Canadian clinical stage pharmaceutical development company, is pleased to announce that its subsidiary Algernon NeuroScience (AGN Neuro), along with the Centre for Human Drug...

at 07:35
Endeavor BioMedicines Raises $132.5 Million Oversubscribed Series C Financing to Advance Pipeline of Transformational Medicines
Endeavor BioMedicines, Inc. ("Endeavor"), a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, today announced the closing of a $132.5...

at 07:30
Leqembi® revenue totaled JPY 2.83 billion in the first quarter 2024
BioArctic AB's (publ) partner Eisai today published the preliminary global revenue for Leqembi during the first quarter 2024, in conjunction with their partner Biogen's first quarter report. In total, sales of JPY 2.83 billion were recorded in the...

at 07:25
RxLightning Celebrates Unprecedented Growth and Achieves Meaningful Medication Access Milestones
RxLightning, creator of the industry's leading platform for streamlining specialty medication access and affordability, is proud to have reached a number of meaningful milestones in the last year ? including significant increases in provider users,...

More news about Health...


News published on and distributed by: